Rossari BiotechNSE:ROSSARI -0.48%85 EBITDA Margin % is 14.14% as of Mar. 2026, which is 0% above its 10-year median of 14.10. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹998.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,585 Chemicals companies, Rossari Biotech ranks better than 63.15% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Rossari Biotech's EBITDA for the
three
months ended in Mar. 2026 was ₹968 Mil. Rossari Biotech's Revenue for the
three
months ended in Mar. 2026 was ₹6,849 Mil. Therefore, Rossari Biotech's EBITDA margin for the quarter that ended in Mar. 2026 was 14.14%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Rossari Biotech EBITDA Margin % Related Terms
Rossari Biotech EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a EBITDA Margin % of 14.14% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Rossari Biotech and its competitors. This is near median its historical median of 14.10. Over the past decade, Rossari Biotech's EBITDA Margin % has ranged from 12.94 to 18.75. According to the industry distribution chart, Rossari Biotech ranks #584 out of 1585 companies in the Chemicals industry, placing it in the top 36.8%.
Is Rossari Biotech's EBITDA Margin % too high?
Rossari Biotech's current EBITDA Margin % of 14.14% is near median its 10-year median of 14.10. Over the past 10 years, this metric has ranged from a low of 12.94 to a high of 18.75. The Chemicals industry median EBITDA Margin % is 9.63. Rossari Biotech's value of 14.14% is 46.8% above this industry median. Based on the distribution chart, Rossari Biotech ranks #584 out of 1585 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #584 out of 1585 companies for EBITDA Margin %. This puts Rossari Biotech in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Rossari Biotech's value of 14.14% is 46.8% above this benchmark. Historically, Rossari Biotech's own EBITDA Margin % has ranged from 12.94 to 18.75 over the past decade. While the company's 10-year median is 14.10 vs. the industry median of 9.63, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current EBITDA Margin % of 14.14% is 46.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current EBITDA Margin % is 14.14%, which is near median its own 10-year median of 14.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.23, compared to a current price of ₹534.85 — trading 46.4% below its estimated fair value. The current EBITDA Margin % is 14.14%, which is near median its 10-year median of 14.10 and 46.8% above the Chemicals industry median of 9.63. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current EBITDA Margin % is 14.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
EBITDA Margin %: 14.14% (near median its 10-year median of 14.10)
GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
Industry Position: 46.8% above the Chemicals median (#584 of 1585)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score
Get the complete analysis for NSE:ROSSARI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
